Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742

Documenti analoghi

• Identification and Structural Characterization of I84C and I84A Mutations That Are Associated with High-Level Resistance to Human Immunodeficiency Virus Protease Inhibitors and Impair Viral Replication
  di: Mo, Hongmei, et al.
  Pubblicazione: (2007)
• In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 2 with Decreased Susceptibility to Lopinavir
  di: Masse, Sherie, et al.
  Pubblicazione: (2007)
• Practical Preclinical Model for Assessing the Potential for Unconjugated Hyperbilirubinemia Produced by Human Immunodeficiency Virus Protease Inhibitors
  di: Kempf, Dale J., et al.
  Pubblicazione: (2006)
• Selection of Resistance in Protease Inhibitor-Experienced, Human Immunodeficiency Virus Type 1-Infected Subjects Failing Lopinavir- and Ritonavir-Based Therapy: Mutation Patterns and Baseline Correlates
  di: Mo, Hongmei, et al.
  Pubblicazione: (2005)
• Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon System
  di: He, Yupeng, et al.
  Pubblicazione: (2008)